Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daroo Sazan Sorena Exir is a pharmaceutical and nutraceutical company based in Iran that specializes in the development and manufacturing of generic medicines and dietary supplements. The company operates advanced production facilities designed to meet international Good Manufacturing Practice (GMP) standards, producing a variety of dosage forms including tablets, capsules, and oral liquids. Their product portfolio is primarily focused on addressing public health needs in the Middle Eastern region, with a strong emphasis on nutritional health, pain management, and digestive wellness. By combining local manufacturing expertise with high-quality raw materials, Sorena Exir aims to provide affordable and effective healthcare solutions. The company is an active participant in the Iranian domestic market and continues to expand its reach through strategic distribution and product diversification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daroo Sazan Sorena Exir.